- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1878-7479
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism ; day:10 ; month:9 ; year:2020 ; pages:1-15
Neurotherapeutics ; (10.9.2020), 1-15
- Creator
-
Schneider, Susanne A.
Hizli, Baccara
Alcalay, Roy N.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13311-020-00920-8
- URN
-
urn:nbn:de:101:1-2020103022261957101211
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schneider, Susanne A.
- Hizli, Baccara
- Alcalay, Roy N.
- SpringerLink (Online service)
Other Objects (12)
Androgen receptor function and targeted therapeutics across breast cancer subtypes
Melanoma : Biologically Targeted Therapeutics
Plasmonic Material Engineering for Targeted Therapeutics
Molecular genetic mechanisms surrounding x-linked Dystonia-Parkinsonism
Rethinking medulloblastoma from a targeted therapeutics perspective
Sporadic Parkinsonism
Lysosome‐Targeted Bifunctional Therapeutics Induce Autodynamic Cancer Therapy
Genetics of Parkinsonism
Post-dengue parkinsonism
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Progress and challenges towards targeted delivery of cancer therapeutics
Androgen receptor function and targeted therapeutics across breast cancer subtypes
Melanoma : Biologically Targeted Therapeutics
Plasmonic Material Engineering for Targeted Therapeutics
Molecular genetic mechanisms surrounding x-linked Dystonia-Parkinsonism
Rethinking medulloblastoma from a targeted therapeutics perspective
Sporadic Parkinsonism
Lysosome‐Targeted Bifunctional Therapeutics Induce Autodynamic Cancer Therapy
Genetics of Parkinsonism
Post-dengue parkinsonism
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Progress and challenges towards targeted delivery of cancer therapeutics
Androgen receptor function and targeted therapeutics across breast cancer subtypes
Melanoma : Biologically Targeted Therapeutics
Plasmonic Material Engineering for Targeted Therapeutics
Molecular genetic mechanisms surrounding x-linked Dystonia-Parkinsonism
Rethinking medulloblastoma from a targeted therapeutics perspective
Sporadic Parkinsonism
Lysosome‐Targeted Bifunctional Therapeutics Induce Autodynamic Cancer Therapy
Genetics of Parkinsonism
Post-dengue parkinsonism
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics